Literature DB >> 29698767

Regulation of neural differentiation, synaptic scaling and animal behavior by MeCP2 phophorylation.

Xiaofen Zhong1, Hongda Li2, Jason Kim2, Qiang Chang3.   

Abstract

Highly expressed in the mammalian brain and widely distributed across the genome, MeCP2 is a key player in recognizing modified DNA and interpreting the epigenetic information encoded in different DNA methylation/hydroxymethylation patterns. Alterations in sequence or copy number of the X-linked human MECP2 gene cause either Rett syndrome (RTT) or MECP2 duplication syndrome. Alterations in MECP2 levels have also been identified in patients with autism. To fully understand the significant role of MECP2 in regulating the development and function of the nervous system, it is important to study all aspects of MeCP2 function. Stimulus-induced MeCP2 phosphorylation has been shown to influence the proliferation and differentiation of neural progenitor cells, synaptic scaling, excitatory synaptogenesis, and animal behavior. However, all of the previous functional evidence is from studying phospho-dead mutations. In addition, the relationship between phosphorylation events at multiple sites on the MeCP2 protein is not well understood. Here, we report the generation of a phospho-mimic knockin Mecp2 mouse line. At the synaptic and behavioral levels, the phospho-mimic Mecp2 mice show phenotypes opposite to those observed in phospho-dead mutation at the same phosphorylation site. Moreover, we report opposite phenotypes between phospho-mutants of two sites on the MeCP2 protein. Our new data further confirm the functional significance of specific MeCP2 phosphorylation event and support the opposing regulatory role between different MeCP2 phosphorylation events.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  MeCP2; Phosphorylation; Rett syndrome; S421; S80

Year:  2018        PMID: 29698767      PMCID: PMC6200650          DOI: 10.1016/j.nlm.2018.04.014

Source DB:  PubMed          Journal:  Neurobiol Learn Mem        ISSN: 1074-7427            Impact factor:   2.877


  28 in total

1.  Differential regulation of MeCP2 phosphorylation in the CNS by dopamine and serotonin.

Authors:  Ashley N Hutchinson; Jie V Deng; Dipendra K Aryal; William C Wetsel; Anne E West
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

2.  Insight into Rett syndrome: MeCP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation.

Authors:  Mona D Shahbazian; Barbara Antalffy; Dawna L Armstrong; Huda Y Zoghbi
Journal:  Hum Mol Genet       Date:  2002-01-15       Impact factor: 6.150

3.  MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin.

Authors:  X Nan; F J Campoy; A Bird
Journal:  Cell       Date:  1997-02-21       Impact factor: 41.582

4.  MeCP2 phosphorylation is required for modulating synaptic scaling through mGluR5.

Authors:  Xiaofen Zhong; Hongda Li; Qiang Chang
Journal:  J Neurosci       Date:  2012-09-12       Impact factor: 6.167

5.  Neuronal MeCP2 is expressed at near histone-octamer levels and globally alters the chromatin state.

Authors:  Peter J Skene; Robert S Illingworth; Shaun Webb; Alastair R W Kerr; Keith D James; Daniel J Turner; Rob Andrews; Adrian P Bird
Journal:  Mol Cell       Date:  2010-02-26       Impact factor: 17.970

6.  Activity-dependent scaling of quantal amplitude in neocortical neurons.

Authors:  G G Turrigiano; K R Leslie; N S Desai; L C Rutherford; S B Nelson
Journal:  Nature       Date:  1998-02-26       Impact factor: 49.962

7.  Phosphorylation of MeCP2 at Serine 80 regulates its chromatin association and neurological function.

Authors:  Jifang Tao; Keping Hu; Qiang Chang; Hao Wu; Nicholas E Sherman; Keri Martinowich; Robert J Klose; Carolyn Schanen; Rudolf Jaenisch; Weidong Wang; Yi Eve Sun
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-18       Impact factor: 11.205

8.  Dynamic DNA methylation programs persistent adverse effects of early-life stress.

Authors:  Chris Murgatroyd; Alexandre V Patchev; Yonghe Wu; Vincenzo Micale; Yvonne Bockmühl; Dieter Fischer; Florian Holsboer; Carsten T Wotjak; Osborne F X Almeida; Dietmar Spengler
Journal:  Nat Neurosci       Date:  2009-11-08       Impact factor: 24.884

9.  MECP2 promoter methylation and X chromosome inactivation in autism.

Authors:  Raman P Nagarajan; Katherine A Patzel; Michelle Martin; Dag H Yasui; Susan E Swanberg; Irva Hertz-Picciotto; Robin L Hansen; Judy Van de Water; Isaac N Pessah; Ruby Jiang; Wendy P Robinson; Janine M LaSalle
Journal:  Autism Res       Date:  2008-06       Impact factor: 5.216

10.  Loss of activity-induced phosphorylation of MeCP2 enhances synaptogenesis, LTP and spatial memory.

Authors:  Hongda Li; Xiaofen Zhong; Kevin Fongching Chau; Emily Cunningham Williams; Qiang Chang
Journal:  Nat Neurosci       Date:  2011-07-17       Impact factor: 24.884

View more
  2 in total

1.  The key genes, phosphoproteins, processes, and pathways affected by efavirenz-activated CYP46A1 in the amyloid-decreasing paradigm of efavirenz treatment.

Authors:  Alexey M Petrov; Natalia Mast; Yong Li; Irina A Pikuleva
Journal:  FASEB J       Date:  2019-05-07       Impact factor: 5.834

2.  Detection of Rare Methyl-CpG Binding Protein 2 Gene Missense Mutations in Patients With Schizophrenia.

Authors:  Chia-Hsiang Chen; Min-Chih Cheng; Ailing Huang; Tsung-Ming Hu; Lieh-Yung Ping; Yu-Syuan Chang
Journal:  Front Genet       Date:  2020-05-08       Impact factor: 4.599

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.